Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer

BACKGROUND: Recent phase III randomized trials have suggested that neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS) is a treatment option for patients with advanced epithelial ovarian cancer. This study aimed to use CA-125 and computed tomography (CT) scanning to generate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kazuto, Kitahara, Yoshikazu, Nishimura, Toshio, Yamashita, Soichi, Kigure, Keiko, Ito, Ikuro, Kanuma, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427056/
https://www.ncbi.nlm.nih.gov/pubmed/32791996
http://dx.doi.org/10.1186/s12957-020-01978-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427056/
https://www.ncbi.nlm.nih.gov/pubmed/32791996
http://dx.doi.org/10.1186/s12957-020-01978-6

Ejemplares similares